Clinical Trials Browser

Has announcements × atezolizumab × Gastrointestinal × Clear all

NCT03434379 2023-10-23

IMbrave150

Phase 3 Completed

558 enrolled 48 charts 2 FDA

Gastrointestinal

Carcinoma, Hepatocellular